RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Study Supports Anti-Arrhythmic Effects of Ranolazine in Patients with Acute Coronary Syndrome
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 5
SP 13
OP 14
DO 10.1177/155989770700700509
UL http://mdc.sagepub.com/content/7/5/13.abstract
AB Ranolazine, an anti-ischemic agent approved for use in the treatment of chronic angina, has also been shown to have anti-arrhythmic effects in experimental models. The MERLIN-TIMI 36 trial was the first study in which the anti-arrhythmic effects of ranolazine were evaluated in humans.